MedPath

A clinical trial to compare the effect of two drugs, dexmedetomidine and esmolol as blood pressure controlling agents in patients undergoing ENT surgeries.

Phase 3
Conditions
Health Condition 1: null- ASA grade I-II patients of both sexes aged between 18-60 yrs, undergoing Otorhinolaryngeal (ENT) surgeries.
Registration Number
CTRI/2017/03/008077
Lead Sponsor
Dr Shilpa bansal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Patients aged 18- 60 yrs of both the sexes, undergoing planned Otorhinolaryngeal (ENT) surgeries with ASA grade I-II.

Exclusion Criteria

1.Patients refusing to give informed consent.

2.Patients with recurrent sinus surgery and patients with systemic co-morbidities like hypertension, coronory artery disease, renal or hepatic disease, cerebro vascular accidents.

3.Patients with coagulopathies or receiving drugs which have effects on coagulation profile.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
primary outcome is to compare the quality of the surgical field using a predefined category scaleTimepoint: surgical field score
Secondary Outcome Measures
NameTimeMethod
compare the efficacy and safety of dexmedetomidine with Esmolol as a hypotensive agent in ENT surgeries with attention on analgesia requirement, recovery profile, and tolerability in adult patients.Timepoint: sedation score, visual analogue score, modified aldrete score
© Copyright 2025. All Rights Reserved by MedPath